RGS8 are mostly small proteins of 20-30 kDa that consist almost entirely of the conserved RGS domain. In contrast, members of the C/R7 subfamily such as RGS7 and RGS9-2 are much larger possessing multiple domains, such as DEP (disheveled, pleckstrin) and GGL (G protein gamma subunit-like). These motifs participate in interactions with signaling and/or structural proteins and contribute to the stability, localization and non-GAP-related functions of RGS proteins (Siderovski and Willard 2005) . However, there is considerable diversity in the conserved RGS domains themselves that contributes to Ga protein binding selectivity (Soundararajan et al. 2008 ) and as such these regions are potential drug targets to disturb RGS-Ga protein interactions (Roof et al. 2006; Roman et al. 2007) . For example, the RGS domain of RGS4 shares 58% homology to the closely related R4 family member RGS8 and only 35% homology with RGS7. Yet, small molecules have been identified that selectively inhibit RGS4 but not RGS8, both in terms of Gao binding and functional regulation of Gao-mediated inhibition of adenylyl cyclase (AC) (Roman et al. 2007 ). In addition, RGS4 and RGS8 both bind to and functionally regulate Gai and Gaq whereas RGS7 is selective for Gao (Posner et al. 1999; Lan et al. 2000) .
Here, we compare the ability RGS4 and RGS8, which consist mostly of the RGS domain, with the RGS domain of RGS7 (RGS7-box) to regulate mu-opioid receptor signaling to AC via Gai/o proteins. These RGS proteins are expressed in brain regions rich in mu-opioid receptors and participate in the manifestation of clinically relevant opioid behaviors. For example, the thalamus, a mu-opioid receptor-rich relay station for transmitting pain information and the locus coeruleus, a noradrenergic center that influences opioid withdrawal behavior, are enriched in RGS4, RGS8 and RGS7 (Gold et al. 1997; Ingi and Aoki 2002; Chao and Nestler 2004) . In addition, RGS4, RGS8 and the R7 family member, RGS9, are highly expressed in the nucleus accumbens, a region within the striatum thought to mediate the rewarding properties of addictive drugs such as morphine and the caudate putamen, which is involved in the locomotor-stimulating properties of opioids (Gold et al. 1997; Ingi and Aoki 2002; Chao and Nestler 2004) .
Most studies comparing selectivity of RGS proteins in whole cell systems have relied on manipulating RGS protein by heterologous over-expression in transfected cell lines or by genetic knockdown or deletion. Accurately quantifying levels of the manipulated protein in these systems is problematic, making it difficult to establish relationships between RGS protein concentration and effect. Moreover, little information is available regarding the direct comparison between these RGS proteins to regulate a given opioid receptor response. Consequently, we have used digitoninpermeabilized rat C6 glioma cells stably expressing the muopioid receptor (C6l) and Gai2 (Charpentier et al. 1993) to directly compare the effects of purified RGS4 and RGS8, with RGS7-box on mu-opioid inhibition of forskolin (Fsk)-stimulated AC activity. A similar permeabilized-cell system has been used to determine the relative effect of several RGS proteins, including RGS4, on Ca 2+ responses stimulated by Gq-coupled receptors (Hepler et al. 1997; Xu et al. 1999) . Dramatic differences in the regulation of opioid receptor inhibition of AC were observed between the R4 family members and the RGS domain of RGS7 which depend on the cognate Ga protein involved.
Materials and methods

Chemicals and reagents
Tissue culture media, Geneticin, fetal bovine serum, trypsin, Zeocin and LipofectAMINE Plus were purchased from Invitrogen (Carlsbad, CA, USA). Digitonin was obtained from Gallard-Schlesinger (Plainview, NY, USA). cAMP kits were purchased from GE Healthcare (Piscataway, NJ, USA). c[ 
Cell culture
Rat C6 glioma cells stably expressing the mu-opioid receptor (C6l) were grown on 100 mm culture dishes under 5% CO 2 in high glucose Dulbecco's modified Eagle's medium containing 10% fetal bovine serum and in the presence of Geneticin (0.5 mg/mL) to maintain stable expression of the mu-opioid receptor (Lee et al. 1999) . Cells were also transfected with human pertussis toxin (PTX)-insensitive Gai2 C352I or Gao C351I without or with a FLAGtag on the N-terminus (FLAG-Gai2 C352I or FLAG-Gao C351I ) or RGS-insensitive Gao CI/G184S or Gai2 CI/G184S using LipfectAMINE Plus reagent and grown in the presence of zeocin (0.4 mg/mL) to promote stable expression (Clark et al. 2003 (Clark et al. , 2008 . Clones were matched for equivalent levels of Ga expression by western blot and for level of mu receptor expression (Clark et al. 2008) .
Protein purification RGS proteins were expressed as native or glutathione-S-transferase fusion-proteins and purified as described previously (Lan et al. 1998; Roman et al. 2007 ). Gao and Gai2 were expressed as 6XHIS-fusion proteins and purified from transformed BL21-DE3 Escherichia coli as previously described (Linder and Gilman 1991 (Clark et al. 2003) . Briefly, membranes from cells treated with or without PTX (100 ng/mL) overnight were incubated for 60 min in a shaking water bath at 25°C with 20 mM Tris-HCl, pH 7.4, 5 mM MgCl 2 , 100 mM NaCl, 0.1 mM dithiothreitol (freshly prepared), 30 lM GDP, 0.1 nM [
35 S]GTPcS and 0.01-10 lM DAMGO or dH 2 O. Samples were filtered through glass-fiber filters mounted in a Brandel cell harvester and rinsed three times with icecold 50 mM Tris-HCl, pH 7.4, 5 mM MgCl 2 and 100 mM NaCl. Radioactivity retained on filters was counted by liquid scintillation counting in 4 ml of EcoLume scintillation mixture (ICN, Aurora, OH, USA).
Permeabilization
Cells were pelleted, washed once in ice-cold modified KGEH buffer (140 mM potassium glutamate, 10 mM EDTA, 3 mM HEPES, 4 mM MgCl2, pH 7.4) and resuspended in the same buffer containing 20 lM digitonin. The cell suspension was incubated at 37°C (5 min), pelleted, washed and resuspended in assay buffer (128 mM NaCl, 2.4 mM KCl, 3 mM MgSO 4 , 2 mM NaHCO 3 , 10 mM Na 2 HPO 4 and 10 mM Glucose, 10 uM GTP, 100 uM ATP, pH 7.4) + 2 mM 3-isobutyl-1-methylxanthine. The degree of permeabilization was determined after each assay by trypan blue exclusion. The addition of digitonin routinely resulted in ‡ 90% trypan blue positive cells; £ 10% of cells were positive for trypan blue when digitonin was excluded.
Assay of AC activity
One hundred microliters of cells were added to an equal volume of assay buffer containing Fsk to stimulate AC activity, purified RGS proteins and any additional agonists or antagonists. The reaction mixture was incubated for 15 min in a shaking water bath (37°C) and stopped by the addition of ice-cold perchloric acid. The activity of AC was then determined as the accumulation of cAMP measured by radioimmunassay essentially as described previously (Clark et al. 2008) .
RGS-stimulated GTPase
Single turnover GTP hydrolysis measurements with and without RGS7 were based on Roof et al. (2006) . Briefly, 200 nM Ga o was loaded with a threefold molar excess of c[ 32 P]GTP in 20 mM HEPES, 20 mM EDTA pH 8.0 for 5 min at room temperature and then cooled on ice. The loaded Ga o was then added to equal volumes of ice-cold initiation buffer (20 mM HEPES, 40 mM MgCl 2 pH 8.0 and 5-20 lM unlabeled GTP) containing RGS7 such that the final concentration was 0 or 127 nM, with no more then 2% dimethylsulfoxide. After incubation for various times on ice, the reaction was quenched with 5% activated charcoal in buffer containing 20 mM sodium phosphate buffer (pH 2.0). After 20 min, the charcoal was centrifuged and the supernatant counted in a Perkin Elmer TopCount 96 well plate counter by Cerenkov counting. The amount of [ 32 P]P i released at each time point was fit to an exponential function to calculate the rate constant:
Fitting constraints were setting counts (t = 0) for each curve to the average of the counts (t = 0) for the experiment and setting counts (t = 30 min) to the same value for all curves in an experiment.
Steady-state GTPase assay
C6l cells were treated overnight with 100 ng/mL PTX and membranes were prepared as described (Clark et al. 2003) . Membranes (15-30 mg/tube) were pre-incubated for 5 min at 30°C with 20 mM Tris-HCl, pH 7.4, 5 mM MgCl 2 , 100 mM NaCl, 0.2 mM EDTA, 1 mM dithiothreitol (freshly prepared), an ATP-regenerating system (0.2 mM ATP, 0.2 mM AppNHp, 50 units/mL creatine phosphokinase and 5 mM phosphocreatine), with or without 1 lM RGS protein and with or without 10 lM DAMGO. To start the assay, [c 32 P]GTP (diluted to 200 000-500 000 cpm/ tube) was added to a final concentration of 0.1 lM. After 2 min, the assay was stopped by adding ice-cold 15% charcoal with 20 mM phosphoric acid in 0.1% gelatin. Samples were allowed to sit on ice for 30 min, centrifuged and 32 Pi in the supernatant was measured by liquid scintillation counting as described (Clark et al. 2003) .
Flow cytometry protein interaction assay
For flow cytometry interaction studies, RGS proteins were biotinylated with amine-reactive Biotin 3-sulfo-N-hydroxysuccinimide ester sodium salt in a 2 : 1 stoichiometry (biotin : RGS). Gao was chemically labeled with Alexa Fluor R 532 carboxylic acid succinimidyl ester (Invitrogen) at a stoichiometry of 3 : 1 (fluor : protein). Excess biotin/fluor labels were removed by purification on 1 mL Sephadex G25 spin columns. Activity and effective concentration of Gao was determined post-labeling using [ 35 S]GTPcS. Biotinylated RGS4 or RGS7 proteins were preincubated with LumAvidin microbeads, washed and allowed to associate with AIF 4 -activated AF532-labeled Gao for 30 min in a 96-well plate. The RGS-Gao interaction was then measured on a Luminex 100IS flow cytometer as the median fluorescence intensity. Increasing concentrations of unlabeled Gai2 were added to compete for RGS protein binding.
Data analysis
All concentration response and rate data were analyzed using Graphpad Prism (San Diego, CA, USA) to determine rate constants, potency (EC 50 values) and maximal effects.
Results
AC assays in permeabilized cells
Cell permeabilization has been used extensively to introduce macromolecules such as non-permeable ions, small molecules and exogenous proteins to the cell interior without significantly disrupting cell architecture and signaling complexes (see Schulz 1990 for review). Rat C6 glioma cells expressing the mu opioid receptor (C6l) have been permeabilized by treatment with digitonin, a mild non-ionic detergent, while leaving receptor coupling to G proteins intact (Alt et al. 2001) . To determine the contribution of individual RGS proteins to the regulation of opioid signaling to downstream effectors, conditions were optimized for assaying AC activity in permeabilized cells in suspension.
Greater than 90% permeabilization of suspended C6l cells as measured by Trypan blue exclusion was obtained following treatment of cells with 20 lM digitonin (5 min, 37°C; Table 1 ). In contrast, treatment of cells in an identical manner but without digitonin resulted in less than 10% cells stained, presumably because of manipulation during the suspension procedure. The degree of permeabilization produced by digitonin treatment was sensitive to incubation temperature and cell concentration but not incubation time (data not shown). Treatment of intact, non-permeabilized, cells with Fsk produced a robust increase in AC activity measured as the accumulation of cAMP (Table 1) . Fsk was ineffective in cells permeabilized with digitonin (Table 1) , likely the result of the depletion of intracellular ATP concentrations required for AC activity (Brooker and Pedone 1986) , and was rescued by the addition of ATP to the assay buffer. Importantly, in the presence of ATP, Fsk stimulation of AC was equipotent in permeabilized versus intact cells (Table 1) . DAMGO, a mu-opioid specific agonist, produced similar maximum inhibition in control and permeabilized cells but inhibited Fsk-stimulated AC activity with a slightly reduced potency in permeabilized cells (25 ± 13 nM) compared with control cells (4.9 ± 2.6 nM; Fig. 1 ). These data demonstrate that opioid signaling to AC through the mu receptor remains intact in digitonin-permeabilized C6l cells.
RGS protein regulation of opioid signaling to AC
To determine whether exogenous RGS proteins modulate opioid coupling to AC in permeabilized cells we used DN-RGS4, a modified RGS4 protein lacking 18 amino acids at the N-terminus (Krumins et al. 2004; Roman et al. 2007) . Increasing concentrations of DN-RGS4 (EC 50 720 ± 280 nM) resulted in a profound loss of DAMGO inhibition of Fsk-stimulated AC (Fig. 2a) . There was no effect of purified DN-RGS4 on basal levels of AC activity (data not shown) or on Fsk-stimulated cyclase in the absence of DAMGO (Fig. 2b) . These data are consistent with the role of RGS4 as a GAP that attenuates G protein-mediated signaling to AC.
To confirm that the effect of DN-RGS4 was the result of GAP activity, a model was utilized in which the GAP effects of RGS proteins are silenced by a Gly-Ser mutation at position 184 in the switch I region of Ga that disrupts its EC 50 values were determined from three independent curves and are the mean ± SEM. Optimal concentrations of ATP (100 lM) and digitonin (20 lM) were empirically determined (data not shown). association with RGS proteins (Clark et al. 2003; Clark and Traynor 2004) . Rat C6l cell clones were generated that stably express PTX-insensitive Gai2 that are either sensitive (RGS-s) or insensitive (RGS-i) to RGS-mediated GAP activity. Clones were matched for equal Gai2 expression as assessed by western blot (Fig. 3a, inset) Fig. 3a) . In PTX-treated cells expressing RGS-i Gai2, DAMGO was nearly twice as efficacious (61% maximum inhibition of Fskstimulated AC activity) and almost 20 times more potent (EC 50 : 3.8 ± 0.9 nM) than cells expressing RGS-s Gai2 (35%; EC 50 : 147 ± 92 nM) (Fig. 3b) because of the loss of endogenous RGS protein activity at Gai2 through the RGSinsensitive mutation. DN-RGS4 (1 lM) attenuated inhibition of AC activity by near-maximal concentrations of DAMGO in cells expressing RGS-s but not RGS-i Gai2 (Fig. 3c ).
RGS4 and RGS8 are two closely related members of the R4 family of RGS proteins that share 58% sequence identity and consist almost entirely of the canonical RGS domain (Hollinger and Hepler 2002) . The inhibition of AC activity by a range of DAMGO concentrations in the presence of a maximal concentration of RGS protein showed that the potency of DAMGO (EC 50 : 53 ± 13 nM) was reduced similarly by RGS4 (to 830 ± 730 nM) and RGS8 (to 400 ± 220 nM) (Fig. 4a) . Moreover, RGS4 and RGS8 decreased the maximal effect of DAMGO by $50%, indicating that even maximal concentrations of DAMGO were unable to overcome the negative regulation imposed by the RGS proteins. Increasing concentrations of purified RGS4 and RGS8 attenuated the inhibition of AC by DAMGO (100 nM) with similar potency ( Fig. 4b ; EC 50 : 710 ± 380 nM vs. 240 ± 100 lM, respectively).
In contrast to RGS4 and RGS8, addition of purified RGS7-box, comprising mainly the 120 amino-acid RGS domain (aa 156-341; Lan et al. 1998) had no effect on opioid inhibition of AC activity, even at concentrations up to 10 lM (Fig. 4b) . However, the same preparation of RGS7-box exhibited GAP activity at Gao in the single turnover GTP hydrolysis assay, demonstrating that this protein does possess viable GAP activity (Fig. 4c) . The predominate Gai/o protein expressed in rat C6 glioma cells is Gai2 (Charpentier et al. 1993) , and data suggest that opioid receptors preferentially couple to AC via Gai2 relative to other Gai/o family members (Moon et al. 2001) . In vitro, RGS7 is a less potent GAP at Gai2 (Lan et al. 2000; Hooks et al. 2003) ; therefore, we hypothesized that RGS7-box did not regulate mu-opioid inhibition of AC because of inefficient regulation of opioid-stimulated Gai2. To address this the GAP activity of RGS7-box and RGS8 was directly compared via DAMGO-stimulated steady state GTPase activity in membranes prepared from PTXtreated C6l cells stably expressing PTX-insensitive Gao (C351I) or Gai2 (C351I) (Clark et al. 2006) . Robust GAP activity was induced at both Gai2 and Gao by RGS8 (1 lM), which increased DAMGO-stimulated GTP hydrolysis by more than threefold showing no Ga selectivity (Fig. 5a and  b) . In contrast, RGS7-box at a higher concentration (5 lM) increased DAMGO-stimulated GTPase activity of Gao by twofold (Fig. 5a ) but had no effect on Gai2 (Fig. 5b) . Indeed, RGS7-box antagonized the ability of RGS8 to inhibit DAMGO-mediated inhibition of AC (Fig. 5c) . These findings confirm those of Hooks et al. (2003) demonstrating that more efficacious RGS proteins can be antagonized by those with weak activity towards a particular Ga subunit.
To determine if this antagonism was because of the ability of RGS7 box to bind Gai2 without promoting significant GAP activity the direct interaction of RGS proteins at Gao and Gai2 was tested using a flow cytometry-based protein interaction assay. This assay makes use of purified RGS protein that is immobilized to avidin-coated microspheres through a biotin linkage. The immobilized RGS protein is then allowed to interact with AIF 4 -activated Alexa532-labeled Ga protein. Fluorescence resulting from the RGS/Ga association is monitored and quantified by flow cytometry. This method has been used previously to quantify the binding affinity of RGS4 with Gao subunits (Roman et al. 2007 ). Gai2 competed with fluorescently labeled AF532-Gao for binding to RGS4 resulting in the loss of fluorescence (Fig. 6) . In contrast, fluorescence resulting from the RGS7-box/AF532-Gao association was weakly disrupted by the presence of unlabeled Gai2 and only at high concentrations. These data confirm that RGS7-box fails to act as a GAP for opioid signaling in C6 l cells as a result of its low binding affinity for Gai2 (Lan et al. 2000) . However, the binding is sufficient that at high concentrations the RGS domain of RGS7 can antagonize the actions of RGS proteins with higher binding affinity, without promoting GTPase activity itself.
Discussion
The purpose of this study was to quantitatively compare the ability of individual RGS proteins to regulate opioid signaling to downstream effectors. The ability to establish concentration-effect relationships for RGS proteins using permeabilized cells allows for the activity of individual RGS proteins to be determined and compared. Using an ACcoupled system, the RGS domains of RGS4 and RGS8 were seen to be equally effective whereas, RGS7-box lacked GAP activity towards Gai2. Indeed, RGS7-box antagonized the GAP activity of the more efficacious RGS8. These findings ), to calculate the rate constant (k). Fitting constraints included setting counts (t = 0) for each curve to the average of the counts (t = 0) for the experiment and setting counts (t = 30 min) to the same value for all curves in an experiment. Data are the mean ± SEM of four independent experiments performed in triplicate.
are consistent with results using purified in vitro systems wherein both RGS7-box (Lan et al. 2000) and the full length RGS7 (Hooks et al. 2003) are particularly poor GAPs at Gai and Gao relative to members of the R4 family RGS4 or RGS8 and where the less efficacious RGS7 antagonizes the GAP activity of more robust RGS proteins (Hooks et al. 2003) .
Comparison of residues within the RGS domains of RGS4, RGS8 and RGS7 points to structural determinants that may underlie their differences in binding to Ga proteins. Based on the structure of the RGS4-Gai1 complex (Tesmer et al. 1997) , specific contact sites between the RGS domain and switch regions I, II and III of Gai1 have been resolved. Sequence analysis of these regions shows that RGS4 and RGS8 share identical homology in those residues projected to contact Gai; however, RGS7 differs in at least eight residues within the same regions, including several residues directly implicated in forming the proposed Gai-binding contact site. Of these, the most likely to account for differences in Gai binding are those residues immediately surrounding Asn 128 given its involvement in forming the conserved RGS domain (Tesmer et al. 1997) . For example, there is an interaction between the conserved Arg 134 of RGS4 and a highly conserved Glu in Switch III of Ga. In RGS7 this Arg is substituted with Tyr and so there are likely compensatory interactions, as occurs with RGS9 in which Arg 134 is replaced by Met (Slep et al. 2001) . This differential interaction between Ga proteins and the RGS domains of R4 and 7 family members, especially in key residues forming the RGS/Gai interface imply that the RGS domain itself contributes to selectivity exhibited by RGS proteins by dictating the affinity of Ga binding and therefore the strength of GAP regulation (Soundararajan et al. 2008) .
The physiologic effects of the opioid system are mediated almost exclusively by the Gao/i family of G proteins and are therefore subject to RGS-mediated GAP regulation. Both RGS4 and RGS8 are enriched in the thalamus (Gold et al. 1997) , a region dense in mu opioid receptor expression that functions as a relay station for transmitting pain information, and there is considerable in vitro evidence that RGS4 and RGS8 act as GAPs for opioid-mediated signaling (Saitoh Fig. 6 Antagonism of RGS8 activity by RGS7-box. Inhibition of forskolin-stimulated AC by DAMGO (100 nM) was measured in the presence of either RGS7-box (5 lM), RGS8 (1 lM) or both (RGS7 + RGS8). Data are expressed as the percentage of the Fsk response and are the mean ± SEM (n = 3-4). Ikeda et al. 2002; Clark et al. 2003) . This may be of particular interest given that RGS4 )/) mice show no observable opioid-related phenotype (Grillet et al. 2005) pointing to a functional redundancy between RGS4 and RGS8 in vivo. In addition, gene deletion and/or knockdown studies have also implicated members of the R7 family, including RGS7 and RGS9-2, in the regulation of actions of morphine and other mu-opioids drugs in vivo (Garzon et al. 2003; Zachariou et al. 2003) . However, the present results suggest these effects may be specific for opioid actions mediated by Gao rather than Gai2. Data from our study and others (Lan et al. 2000; Hooks et al. 2003) indicate poor GAP regulation of Gai2 by both the RGS domain of RGS7 (RGS7-box) and full length RGS7 co-expressed with its binding partner Gb5 to promote stability. Although muopioid receptors couple to Gai2 in cloned cell lines (Clark et al. 2003 ) the contribution of this Ga protein to the in vivo actions of opioids is unknown. However, several studies suggest Gai2 may contribute to opioid anti-nociception in certain rodent models of pain (Raffa et al. 1994; SanchezBlazquez et al. 1995) . Also, in spite of the fact that RGS7 does not act as a GAP towards Gai2 in the present experiments, it is able to antagonize the actions of RGS8, suggesting it does bind Gai2 to some extent as indicated by the flow cytometry-based protein interaction assay. The low affinity of RGS7 box for Gai2, is in line with the reported low catalytic activity of RGS7 box towards Gai2, which is 100-times less than that of RGS4 (Lan et al. 2000) . This raises the possibility that, depending on the relative levels of expression, RGS7 may serve to inhibit the GAP activity of more efficient RGS protein in cells where they are co-expressed.
Finally, our data demonstrate that RGS protein regulation of opioid signaling to downstream effector enzymes such as AC can be characterized in a permeabilized whole-cell model. Such models have been used to study protein function, including the characterization of RGS protein regulation of Gaq-coupled receptor coupling to increases in Ca 2+ release (Xu et al. 1999) . Unlike reconstituted lipid vesicle systems, permeabilized cells allow for study of RGS protein function in a more native signaling environment with endogenously expressed signal transducers and downstream effectors. These methods also allow for precise quantities of purified RGS proteins to be introduced into cells with minimal disruption of the signaling environment relative to cell homogenization/membrane preparations. Because of their relative simplicity, these methods can be extended to other Gai/o-coupled receptor systems and potentially to additional signaling pathways (Hepler et al. 1997; Xu et al. 1999) .
